FDA Adverse Event Malfunction Summary report: N

XIA 3 TITANIUM BLOCKER

MDR report key: 6586506 · Received May 23, 2017

Report

Report Number
0009617544-2017-00217
Event Type
Malfunction
Date Received
May 23, 2017
Date of Event
April 25, 2017
Report Date
July 24, 2017
Manufacturer
STRYKER SPINE-FRANCE
Product Code
MNI
UDI-DI
07613327000993
PMA / PMN Number
K113666
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

CATALOG# 48230000, LOT# EKD. DATE OF EXPLANT: (B)(6) 2017. VISUAL INSPECTION, DEVICE HISTORY REVIEW, COMPLAINT HISTORY REVIEW, RISK ASSESSMENT. MANUFACTURING RECORDS WERE REVIEWED FOR THE CORRESPONDING LOT AND NO RELEVANT ISSUES WERE IDENTIFIED. THE VISUAL INSPECTION OF THE BLOCKERS CONFIRMED INDENTATIONS AT THE BASE OF BLOCKERS. THE MOST LIKELY ROOT CAUSE OF THE EVENT IS THE ACTIVITY LEVEL OF THE PATIENT ALONG WITH ROD NOT FULLY SEATED IN THE SCREW LEADING TO ROD SLIPPAGE.

Description of Event or Problem · 1

IT WAS REPORTED THAT; DURING REVISION SURGERY- WAS NOTED BY SURGEON THAT THERE WAS ROD SLIPPAGE. UPDATE 5/23/2017. THE REASON FOR THE REVISION SURGERY WAS DUE TO PSEUDARTHRITIS, NON FUSION. WHEN THE SURGEON WENT IN TO TREAT THE PSEUDARTHRITIS, THE ROD SLIPPAGE WAS NOTICED. PRIOR TO THE REVISION SURGERY, THERE WAS NO INDICATION/ISSUE NOTICED INVOLVING ANY OF THE PREVIOUS IMPLANTED PRODUCTS.

Description of Event or Problem · 1

IT WAS REPORTED THAT; DURING REVISION SURGERY- WAS NOTED BY SURGEON THAT THERE WAS ROD SLIPPAGE. UPDATE (B)(6) 2017. THE REASON FOR THE REVISION SURGERY WAS DUE TO PSEUDOARTHRITIS, NON FUSION. WHEN THE SURGEON WENT IN TO TREAT THE PSEUDOARTHRITIS, THE ROD SLIPPAGE WAS NOTICED. PRIOR TO THE REVISION SURGERY, THERE WAS NO INDICATION/ISSUE NOTICED INVOLVING ANY OF THE PREVIOUS IMPLANTED PRODUCTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
367797 XIA 3 TITANIUM BLOCKER PEDICLE SCREW SPINAL SYSTEM MNI STRYKER SPINE-FRANCE 482335030 EKD 07613327000993

Patients

Seq Age Sex Outcome Treatment
1 21 YR